Clobazam in Children with Refractory EpilepsyTwenty three patients with refractory epilepsy (14 males and 9 females) and high seizure frecuency, all younger than 18 years old, were treated with Clobazam (Frizin®) added to conventional anticonvulsants. Doses of 0,5 -2 mg/kg/day, not exceeding 40 rng/day, were used. Complete seizure relief was achieved in 46% of the cases (11 patients) for an average follow up period of 5 months and 27 days. An important reduction in the frecuency of seizures was seen in 21% of the patients (5 cases). Recurrence of seizures after 2 to 3 months of good response to treatment ocurred in 5 patients (21 %). The best results were observed in secondary generalized epilepsies.El tratamiento de la epilepsia refractaria aun represents un desafio clinico a pesar de la introduction de nuevas drogas anticonvulsivantes. Partimos de la base que la monoterapia, con control de niveles plasmaticos es el tratamiento de election, sin embargo en algunos pacientes no se logra buena respuesta con una o mas drogas anticonvulsivantes, muchas de las cuales tienen efectos colaterales potencialmente serios.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.